Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    Paul D. Sponseller.
    Contents:
    Anatomy and normal development in children
    Disorders of skeletal growth and development
    Skeletal syndromes and systemic disorders in pediatric orthopedics
    Neuromuscular disorders in pediatric orthopedics
    Pediatric trauma
    Normal values and medications
    Common procedures.
    Print Access Request
    Location
    Version
    Call Number
    Items
    Books: General Collection (Downstairs)
    RD732.3.C48 S66 2011
    1
  • Article
    Nakayama R, Masuoka M, Hiraga K, Miki T.
    Acta Endocrinol Suppl (Copenh). 1979;229:100-7.
    The mechanism of anti-androgenic action of a steroidal compound, TSAA-291, was summarized and discussed in reference to its drug-designing and structure-activity relationship. The target of the drug-design was to obtain a substance which is inactive in androgenic activity and is capable of antagonistically competing with androgen for the receptor. With this intention, the androgen molecule was rendered with a steric hindrance influencing upon the functional 17 beta-hydroxy group. Introduction of a bulky group at the steroidal position-13 or -16 led to anti-androgenic properties. Intense steric hindrance by introducing an enormously bulky group or complete elimination of the 17 beta-hydroxy group rather decreased the anti-androgenic activity. Of these anti-androgens thus synthesized, TSAA-291 proved to be the most active in the anti-androgen assay and also antagonistic against the uptake of [3H]testosterone by the rat ventral prostate.
    Digital Access Access Options